A novel cell-based sensor detecting the activity of individual basic proprotein 1 convertases 2 3 ABSTRACT 34
The proprotein convertases (PCs) are a family of nine conserved calcium-dependent serine 53 endoproteases that includes the basic PCs PC1/3, PC2, furin, PC4, PACE4, PC5/6, and PC7, 54 as well as the non-basic SKI-1/S1P, and PCSK9 (Seidah & Prat, 2002 , Seidah & Prat, 2007 contribute to atherosclerosis (Stawowy & Fleck, 2005) , neurodegenerative diseases (Bennett, 77 Denis et al., 2000, Lopez-Perez, Seidah et al., 1999) , and to the regulation of inflammation 78 (Wu, Song et al., 2016) . Moreover, several human pathogens hijack basic PCs as essential 79 cellular factors required for their multiplication (Stieneke-Grober, Vey et al., 1992, Thomas, 80 2002) . 81
Considering the potential of basic PCs as drug targets, the development of specific 82 inhibitors is of high priority. The first basic PC inhibitors were irreversible substrate-analogue 83 chloromethyl ketones (CMK), in particular decanoyl-RVKR-CMK with high potency and 84 preferred selectivity for basic PCs (Hallenberger, Bosch et al., 1992) . Macromolecular 85 inhibitor designs included insertion of basic PC K/R-Xn-K/R motifs into the reactive site 86 loop of α1-antitrypsin (Fugere & Day, 2005) or eglin c (Komiyama & Fuller, 2000) . 87
Screening of peptide-based inhibitors from libraries yielded potent polyarginines that inhibit 88 basic PCs at low nanomolar concentrations (Cameron, Appel et al., 2000) . More recent 89 peptidomimetic designs resulted in several potent reversible competitive substrate analogue 90 inhibitors derived from the lead structure phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide 91 that inhibit basic PCs at low nanomolar and even picomolar concentrations (Becker, Hardes et 92 al., 2011 , Becker, Lu et al., 2012 , Becker, Sielaff et al., 2010 , Hardes, Becker et al., 2015 . 93
Despite a few multibasic 2,5-dideoxystreptamine derivatives with low nanomolar inhibition 94 constants (Jiao, Cregar et al., 2006) , most currently available non-peptide small molecule 95 inhibitors for basic PCs show only moderate potency and cross-react between basic PCs, 96 restricting therapeutic applications (Couture, Kwiatkowska et al., 2015) . 97
Conventional biochemical approaches using chromogenic or fluorogenic substrates 98 and purified soluble PCs are suitable for high-throughput screening (HTS) and led to the 99 discovery of several synthetic small molecule inhibitors. However, these HTS assays do not 100 accurately recapitulate the complex cellular context of the basic PC-substrate interaction.
Indeed, a more recent molecular sensor that can quantify PC activities in different sub-cellular 102 compartments revealed that the local sub-cellular environment and spatial 103 compartmentalization of basic PCs critically influences their activities and specificities 104 (Bessonnard et al., 2015; Ginefra et al., 2018; Mesnard and Constam, 2010; Mesnard et al., 105 2011 ). This Cell-Linked Indicator of Proteolysis (CLIP) combines defined sub-cellular 106 trafficking with monitoring of fluorescence resonance energy transfer (FRET) between 107 suitable pairs of fluorophores in high-resolution imaging (Ginefra, Filippi et al., 2018) . The 108 prototypic CLIP consists of secreted enhanced cyan fluorescence protein (eCFP) and mCitrine 109 fused via a flexible linker containing a canonical basic PC recognition motif (Mesnard & 110 Constam, 2010) and allows detection of autocrine and paracrine PC activities at the plasma 111 membrane (Mesnard, Donnison et al., 2011) . Recently published CLIP designs containing 112 cellular targeting signals allow quantitative assessment of basic PC bioactivities within 113 specific subcellular compartments (Ginefra et al., 2018) . Recent studies with these sensors 114 uncovered complementary subcellular distribution of furin and PC7 bioactivities (Ginefra et 115 al., 2018) . In order to inhibit the activity of basic PC in the cellular context, inhibitors must 116 reach critical concentrations within the subcellular compartment(s) containing the bioactive 117 enzyme. Within a defined subcellular compartment, the local milieu, defined by pH, redox 118 potential, and ion concentrations, may further influence inhibitor activity. Moreover, the 119 format of classical HTS assay restricts screening to compounds that inhibit the catalytic 120 activity of the mature enzyme. A cell-based assay opens a broader target-range for potential 121 candidate inhibitors, including biosynthesis and zymogen activation, as well as cellular 122 regulatory factors of basic PCs. The development of cell-based HTS platforms appears 123 therefore promising. Here, we report PCific, a novel cell-based molecular sensor that allows 124 rapid screening of collections of inhibitors and their selectivity toward individual basic PCs 125 within mammalian cells. PC sensor. However, human cell lines commonly used for high throughput small molecule 136 screening co-express several members of the basic PC family at varying combinations and 137 levels (Bessonnard, Mesnard et al., 2015) . A major challenge for the development of a cell-138 based basic PC sensor was therefore the ability to discriminate between individual basic PCs 139 present in the same cell. To overcome this problem, we sought to design a cell-based sensor 140 containing a basic PC recognition sequence that is only inefficiently cleaved by endogenous 141 basic PCs. Specific cleavage of the sensor will be achieved by overexpression of individual 142 PCs in the same cell (in cis), followed by detection of a sensitive reporter released into the 143 supernatant. 144
Most basic PCs process their substrates within the secretory pathway or at the cell 145 surface at neutral or mildly acidic pH. Notable exceptions are PC1/3 and PC2 which are 146 active within acidified secretory granules at an optimum pH <5.5 (Seidah & Prat, 2012) . A 147 major substrate of PC1/3 and PC2 in neuroendocrine tissues is the prohormone 148 proopiomelanocortin (POMC). Specific cleavage of POMC by PC1/3 and PC2 at multiple 149 basic PC recognition sites yields distinct peptides, including α, β, and γ-melanocyte 150 stimulating hormone (Cawley, Li et al., 2016) ( Fig. 1A ). We hypothesized that the acidic pH requirement of PC1/3 and PC2 may render at least some POMC-derived cleavage sites 152 relatively resistant to other endogenous basic PCs. To address this issue, we produced human 153 POMC in HEK293T cells that express endogenous PC2, furin, PACE4, PC5/6, and PC7 154 (Bessonnard et al., 2015) . Despite the absence of secretory granules in this cell type (Seidah 155 & Chretien, 1999) , POMC underwent efficient processing at most cleavage sites, with the 156 notable exception of site 3 that flanks γ3-MSH and is processed by PC1/3 ( we retained only the transmembrane domain and cytosolic tail (residues 756-831) of sortilin-172 1, necessary and sufficient for correct subcellular targeting (Fig. 1C ). For the sake of 173 simplicity, we name our sensor henceforth PCific, an acronym formed by the terms PC and 174 specific. In a first step, we examined the sub-cellular distribution of the sensor. To this end, To further optimize assay conditions, we titrated the ratio of sensor plasmid relative to 226 furin plasmid used for transfection and varied sampling time. Visualization of the results by a 227 heat map revealed that improved signal-to-noise ratios were obtained at higher sensor/furin 228 ratios and after short sampling times (Fig. 4A ). To assess feasibility of HTS with our assay, 229 robustness was determined via its Z'-factor (Z'= 1-(3σc++ 3σc-)/(µc+-µc-), which depends on 230 the sum of the standard deviations of positive and negative controls (σc+ and σc-, respectively) 231 as well as the difference between the mean activity of these controls (μc+ and μc-). Assays 232 with a Z'-factor ≥ 0.5 are considered "excellent" for HTS (Zhang, Chung et al., 1999) . Using 233 transient transfection of the sensor with furin as positive (μc+) and empty vector as negative 234 control (μc-), and sampling of supernatants 22 h post transfection we obtained Z' values 235 between 0.63 ( Fig. 3C ) and 0.74 (Fig. 6A) for PCific, making our sensor highly suitable for 236 HTS. In addition, we included PC7 that represents the phylogenetically most distant basic PC 237 and an interesting drug target in its own right. Similar to furin, overexpression of PC7 resulted 238 in enhanced processing of the cleavable sensor that was reduced by mutation of the cleavage 239 site (Fig. 5A, B) . At short sampling times, a higher sensor/PC7 ratio increased the signal-to-240 noise ratio (Fig. 5C ), similar to the situation with furin ( Fig. 4A ). At later time points, a lower 241 proportion of sensor vs. PC7 seemed favorable ( Fig. 5C ), suggesting a more complex situation 242 when compared to furin. Under optimal assay conditions, PC7-specific cleavage of PCific 243 likewise occurred with a Z'-factor of 0.74 (Fig. 7D) , amenable for HTS. 244 245
Implementation of PCific in an inhibitor screen 246
The robust, rapid, and cost-effective assay format make the PCific sensor a promising 247 candidate for a HTS platform to identify novel basic PC inhibitors from compound libraries. 248
For proof-of-concept, we employed PCific to screen a selected set of peptidomimetic basic 249 et al., 2017) ( Table 1) (Table 1) . In a forward screen, HEK293T cells were 256 co-transfected with PCific and furin, followed by treatment with inhibitors at a concentration 257 of 25 µM (Fig. 6A, B ). Cell viability was monitored under the exact assay conditions by 258
CellTiter Glo® assay and overtly toxic compounds excluded (Fig. 6C ). Most inhibitors 259 significantly blocked furin-specific PCific processing in our HTS assay at the used 260 concentration of 25 µM (Fig. 6B) with the notable exception of hexa-D-arginine, in line with 261 our previous results (Fig. 3F ). For counter-screening, we tested our candidates against PCific 262 processing by PC7 and against our SKI-1/S1P sensor. As expected based on our previous 263 studies, almost all candidates were inactive against the non-basic PC SKI-1/S1P that 264 processes substrates at hydrophobic recognition sites (Seidah, Mowla et al., 1999) ( Fig. 6G , 265 H). The inhibition profile of the candidate compounds against PC7 was more complex and 266 overlapped only partially with furin ( Fig. 6D-F) . Plotting the relative activities of the 267 individual compounds against furin and PC7 revealed that the inhibitors used fell into three 268 categories: 1) compounds with apparent selectivity for furin over PC7, 2) candidates with 269 partial selectivity, and 3) compounds lacking detectable specificity (Fig. 6I ). For validation, 270 we chose two compounds of the first category, the parental compound MI-0227 ( Fig. 6J) and 271 compound MI-1530 ( Fig. 6K) . Performing dose-response characteristics, we confirmed that 272 MI-0227 and MI-1530 show significant selectivity for furin over PC7, respectively. 273
Based on the structural relationships between compounds analyzed (Table 1) Table 2 ). Although limited in scope, our screen demonstrates that our PCific sensor can 295 readily distinguish between general and selective PC inhibitors in a HTS format. 296
DISCUSSION 298
Basic PCs are linked to a wide range of human pathologies, including metabolic disorders, 299 cancer, and infectious diseases, making them attractive targets for therapeutic intervention 300 (Seidah & Prat, 2012) . The development of specific inhibitors is therefore of high priority. To confirm their specificity for basic PCs, inhibitors were further counter-screened for 410 inhibition of endogenous SKI-1/S1P activity. To this end, HEK293T cells were transfected in 411 96 well plates with 100 ng/well of SKI-1/S1P sensor plasmid, or an uncleavable version 412 thereof, serving as a negative control. Background luminescence in cell supernatants was 413 established with uncleavable SKI-1/S1P sensor (0.25% DMSO) and was subtracted from the 414 luminescence obtained with cleavable SKI-1/S1P sensor, with or without inhibitors. 
